3 unknown, 1 recruiting, 1 terminated. 5 Phase 2, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Unknown 3, Recruiting 1, Terminated 1 |
| Phase 1 | 1 | Unknown 1 |
| Phase 3 | 1 | Unknown 1 |
Follow PE regimen: new trials by email Literature Review of PE regimen trials Research Report on PE regimen
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Surufatinib Combined With Chemotherapy Plus Toripalimab or Not in the Treatment of Small Cell Lung Cancer Surufatinib,Etoposide,Cisplatin,Toripalimab, Surufatinib,Etoposide,Cisplatin - Small Cell Lung Carcinoma | Phase 1 / Phase 2 | Unknown | Sun Yat-sen University | 88 | 2021-11-09 | 2022-11-14 |
| The Efficacy of WVI in Patients With Localized Basal Ganglia Intracranial Germ Cell Tumors Whole-ventricle irradiation, Carboplatin/etoposide, Ifosfamide/cisplatin/etoposide - Intracranial Germ Cell CNS Tumor, Childhood | Phase 2 | Recruiting | Beijing Tiantan Hospital | 150 | 2021-09-15 | 2021-11-18 |
| Fluzoparib Combined With Camrelizumab for Maintenance Treatment of Locally Advanced Non-small Cell Lung Cancer Camrelizumab, Fluzoparib, Cisplatin，Pemetrexed - Non-small Cell Lung Cancer | Phase 2 | Unknown | Tianjin Medical University Cancer Institute and Hospital | 65 | 2021-03-01 | 2021-05-11 |
| Safety and Efficacy of FOLFSIM Plus Toripalimab in the Treatment of Advanced or Metastatic Neuroendocrine Carcinoma Simmtecan, 5-FU and l-LV, Toripalimab, Etoposide, Cisplatin - Neuroendocrine Carcinoma of the Bladder | Phase 2 / Phase 3 | Unknown | Peking University | 336 | 2019-06-19 | 2019-06-20 |
| Study to Compare Irinotecan Combined With Cisplatin (IP) Versus Etoposide Combined With Cisplatin (EP) in Advanced and Metastatic Gastrointestinal Pancreatic and Esophageal Neuroendocrine Carcinoma irinotecan cisplatin, Etoposide cisplatin - Neuroendocrine Carcinoma | Phase 2 | Terminated | Peking University | 66 | 2017-04-29 | 2020-01-22 |
Carcinoma, Neuroendocrine (2) · Carcinoma, Non-Small-Cell Lung (1) · Small Cell Lung Carcinoma (1)
Peking University (2) · Beijing Tiantan Hospital (1) · Sun Yat-sen University (1) · Tianjin Medical University Cancer Institute and Hospital (1)
China (5)
Lin Shen (1) · Tao Jiang, MD, PhD (1)